- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04270903
EPR (Electron Paramagnetic Resonance) as Method of Non-invasive Characterization of Melanin Content in Skins With Different Phototypes
Study Overview
Status
Intervention / Treatment
Detailed Description
Electron paramagnetic resonance (EPR), also known as electron spin resonance (ESR), is a spectrometric method enabling the observation of the absorption of energy by the free radicals contained by a sample immerged in a strong homogenous magnetic field. An EPR spectrum reveals only the presence of paramagnetic centers and can thus only be observed with samples containing lone unpaired electrons. In water-containing biological environments, most of free radicals are very reactive and have a very short life. To detect such species, a strategy is to use extrinsic molecules that will react with these species to form EPR measurable adducts. This technique is called "spin trapping". In contrast, the study of stable free radicals does not require the use of spin-trap agents. Melanins are part of the rare stable biological radicals directly observable with EPR. In practice, melanin is the only endogenous stable radical that can be detected using 1 GHz EPR.
The aim of the present study is to measure the EPR signal recorded from skin with different pigmentations. 45 healthy volunteers will be enrolled:
15 subjects with phototype 1-2, 15 subjects with phototypes 3-4, 15 subjects with phototypes 5-6. The parameters described hereafter will be investigated:
- g factor (resonance condition); expected g=2.005;
- shape of the signal, presence of a shoulder at g=2.01 due to pheomelanin;
- intensity of the signal (signal height, double integration, double integration relative to reference).
This will provide a database for other ongoing studies carried out in patients with suspicious lesion (nevi vs melanoma)
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Brussels, Belgium, 1200
- Université Catholique de Louvain
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
45 healthy volunteers
- 15 subjects with skin Phototype I-II
- 15 subjects with Phototype III-IV
- 15 subjects with Phototype V-VI
Description
Inclusion Criteria:
- Healthy volunteers with skin belonging to Phototype I-II, III-IV, V-VI
Exclusion Criteria:
- Subjects under 18 years
- Subjects with pacemakers
- Subjects with non-removable implants with metal or otherwise not known to be MRI-compatible.
- Pregnant women
Study Plan
How is the study designed?
Design Details
- Observational Models: Ecologic or Community
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Phototype I - II
EPR measurement at the surface of the skin (arm)
|
Subject put in a magnet, magnetic field sweeping around 40 mTesla.
Irradiation with a wave with a frequency of 1.1 GHz.
A resonator (surface coil) is put at the surface of the skin (arm).
The EPR signal is recorded.
|
|
Phototype III - IV
EPR measurement at the surface of the skin (arm)
|
Subject put in a magnet, magnetic field sweeping around 40 mTesla.
Irradiation with a wave with a frequency of 1.1 GHz.
A resonator (surface coil) is put at the surface of the skin (arm).
The EPR signal is recorded.
|
|
Phototype V - VI
EPR measurement at the surface of the skin (arm)
|
Subject put in a magnet, magnetic field sweeping around 40 mTesla.
Irradiation with a wave with a frequency of 1.1 GHz.
A resonator (surface coil) is put at the surface of the skin (arm).
The EPR signal is recorded.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Measurement of the EPR signal intensity
Time Frame: Through study completion (6 months)
|
Signal height / Double integration / Double integration relative to reference signal
|
Through study completion (6 months)
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Bernard Gallez, PhD, Université Catholique de Louvain
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- MELA-RPE-PHOTOTYPE
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Skin Pigmentation
-
Ajou University School of MedicineCompletedPigmentation Disorder | PigmentationKorea, Republic of
-
Jin Cheol KimActive, not recruitingPigmentation Disorder | PigmentationKorea, Republic of
-
NovoBliss Research Pvt LtdCompleted
-
Johnson & Johnson Consumer Inc. (J&JCI)CompletedSkin Pigmentation | PhotobiologyUnited States
-
Integrative Skin Science and ResearchSytheon Ltd.Active, not recruitingWrinkle | Skin PigmentationUnited States
-
Chulalongkorn UniversityAgricultural Research Development Agency (Public Organization)CompletedSkin Irritation | Skin PigmentationThailand
-
Cairo UniversityFayoum UniversityRecruitingGlutathione | Gingival Pigmentation | Vitamin C | DepigmentationEgypt
-
ScitonCompleted
-
Cosmetique Active InternationalCompletedHealthy Volunteers | Hyperpigmentation | Skin PigmentationRomania
Clinical Trials on EPR measurement
-
University of Sao Paulo General HospitalActive, not recruitingObstructive Sleep ApneaBrazil
-
Dartmouth-Hitchcock Medical CenterDisarm TherapeuticsCompletedCIPN - Chemotherapy-Induced Peripheral NeuropathyUnited States
-
King's College Hospital NHS TrustBritish Lung FoundationCompleted
-
Philip SchanerNational Cancer Institute (NCI)TerminatedMelanoma | Head and Neck Neoplasms | Carcinoma, Squamous Cell | Carcinoma, Basal Cell | Breast Neoplasm | Neoplasms, Malignant | Skin NeoplasmUnited States
-
Universitaire Ziekenhuizen KU LeuvenAZ Turnhout; AZ Herentals; Heilig Hartziekenhuis, Mol; Noorderhart Pelt; Sint-Jozefskliniek...Recruiting
-
University Hospital, Clermont-FerrandCompletedCoronary Artery Disease | Coronary Artery Bypass | Pulmonary Atelectasis | Anesthesia, General | HypovolemiaFrance
-
Ain Shams UniversityUnknown